SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer - Archive ouverte HAL
Article Dans Une Revue Cell Reports Année : 2024

SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

1 CIC bioGUNE - Center for Cooperative Research in Biosciences = Centro de Investigación cooperativa en biociencia (Derio, Biscay, Espagne)
2 BRTA - Basque Research and Technology Alliance
3 UEX - Universidad de Extremadura - University of Extremadura
4 Biofisika Institute (CSIC, UPV/EHU), 48940 Leioa,
5 CIBERehd - Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas
6 Unipd - Università degli Studi di Padova = University of Padua
7 IMIBIC - Instituto Maimonides de Investigación Biomédica de Cordoba
8 UMH - Universidad Miguel Hernández [Elche]
9 University of Medicine Greifswald
10 UPNA - Universidad Pública de Navarra [Espagne] = Public University of Navarra
11 Scientific Research Centre 'Isla de la Cartuja' (cicCartuja)
12 BPH - Bordeaux population health
13 CHU Bordeaux - Centre Hospitalier Universitaire de Bordeaux
14 UPV / EHU - Universidad del País Vasco [Espainia] / Euskal Herriko Unibertsitatea [España] = University of the Basque Country [Spain] = Université du pays basque [Espagne]
15 Ikerbasque - Basque Foundation for Science
16 MSSM - Icahn School of Medicine at Mount Sinai [New York]
17 BioDonostia Health Research Institute = Instituto de Investigación Sanitaria Biodonostia
18 CIMA - Center for Applied Medical Research [Plamplona]
19 IdiSNA - Navarra Institute for Health Research / Instituto de Investigación Sanitaria de Navarra
20 IBSAL - Instituto de Investigación Biomédica de Salamanca
21 IBGC - Institut de biochimie et génétique cellulaires
22 LCC - Laboratoire de chimie de coordination
23 IPBS - Institut de pharmacologie et de biologie structurale
Krystyna Mazan-Mamczarz
  • Fonction : Auteur
Supriyo De
  • Fonction : Auteur
Myriam Gorospe
  • Fonction : Auteur

Résumé

The posttranslational modification of proteins critically influences many biological processes and is a key mechanism that regulates the function of the RNA-binding protein Hu antigen R (HuR), a hub in liver cancer. Here, we show that HuR is SUMOylated in the tumor sections of patients with hepatocellular carcinoma in contrast to the surrounding tissue, as well as in human cell line and mouse models of the disease. SUMOylation of HuR promotes major cancer hallmarks, namely proliferation and invasion, whereas the absence of HuR SUMOylation results in a senescent phenotype with dysfunctional mitochondria and endoplasmic reticulum. Mechanistically, SUMOylation induces a structural rearrangement of the RNA recognition motifs that modulates HuR binding affinity to its target RNAs, further modifying the transcriptomic profile toward hepatic tumor progression. Overall, SUMOylation constitutes a mechanism of HuR regulation that could be potentially exploited as a therapeutic strategy for liver cancer.
Fichier principal
Vignette du fichier
Lachiondo-Ortega, SUMOylation controls Hu antigen R, 2024.pdf (10.08 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04522023 , version 1 (26-03-2024)

Licence

Identifiants

Citer

Sofia Lachiondo-Ortega, Claudia M Rejano-Gordillo, Jorge Simon, Fernando Lopitz-Otsoa, Teresa C. Delgado, et al.. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. Cell Reports, 2024, 43 (3), pp.113924. ⟨10.1016/j.celrep.2024.113924⟩. ⟨hal-04522023⟩
56 Consultations
23 Téléchargements

Altmetric

Partager

More